Skip to main content

Advertisement

Log in

A Novel Microfluidic Device-Based Neurite Outgrowth Inhibition Assay Reveals the Neurite Outgrowth-Promoting Activity of Tropomyosin Tpm3.1 in Hippocampal Neurons

  • Brief Communication
  • Published:
Cellular and Molecular Neurobiology Aims and scope Submit manuscript

Abstract

Overcoming neurite inhibition is integral for restoring neuronal connectivity after CNS injury. Actin dynamics are critical for neurite growth cone formation and extension. The tropomyosin family of proteins is a regarded as master regulator of actin dynamics. This study investigates tropomyosin isoform 3.1 (Tpm3.1) as a potential candidate for overcoming an inhibitory substrate, as it is known to influence neurite branching and outgrowth. We designed a microfluidic device that enables neurons to be grown adjacent to an inhibitory substrate, Nogo-66. Results show that neurons, overexpressing hTpm3.1, have an increased propensity to overcome Nogo-66 inhibition. We propose Tpm3.1 as a potential target for promoting neurite growth in an inhibitory environment in the central nervous system.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

References

Download references

Acknowledgements

This work was supported by Project Grant APP1083209 from the Australian National Health and Medical Research Council (NHMRC) (T.F.) and Discovery Project Grant DP180101473 from the Australian Research Council (ARC) (T.F.). We thank Tamara Tomanić (UNSW Sydney) for her constructive feedback and critical reading of the manuscript. This work was performed (in part) at the NSW and South Australian node of the Australian National Fabrication Facility under the National Collaborative Research Infrastructure Strategy to provide nano- and microfabrication facilities for Australia’s researchers. M.E.W. would like to acknowledge the support of the Australian Research Council through Discovery Project Grants (DP170103704 and DP180103003) and the National Health and Medical Research Council through the Career Development Fellowship (APP1143377).

Author information

Authors and Affiliations

Authors

Contributions

TF, MEW and TB supervised the project. TF, HS, AH-B and SF designed the research. HS, AH-B, SF and MB performed the research and analysed the data. TF, HS, AH-B and SF wrote the paper. TF, HS, AH-B, AKS, MB and NT edited the paper. All authors read and approved the final manuscript.

Corresponding authors

Correspondence to Majid Ebrahimi Warkiani or Thomas Fath.

Ethics declarations

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial, financial or non-financial relationships that could be construed as a potential conflict of interest.

Ethical Approval

All procedures were conducted in accordance with the Australian Code of Practice for the Care and Use of Animals for Scientific Purposes and were approved by the University of New South Wales Animal Care and Ethics Committee.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 22 KB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Stefen, H., Hassanzadeh-Barforoushi, A., Brettle, M. et al. A Novel Microfluidic Device-Based Neurite Outgrowth Inhibition Assay Reveals the Neurite Outgrowth-Promoting Activity of Tropomyosin Tpm3.1 in Hippocampal Neurons. Cell Mol Neurobiol 38, 1557–1563 (2018). https://doi.org/10.1007/s10571-018-0620-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10571-018-0620-7

Keywords

Navigation